å»çæ©åšå ¬è¡šãããæŽå¯
è¡æ¶²ååè£ çœ®åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033äžççãªè¡æ¶²ååè£ çœ®åžå Žã¯ã2026幎ã«USD 3.40åã§è©äŸ¡ããã2033幎ãŸã§ã«USD 5.70åãã«ã«éãããšäºæ³ããã2026幎ãã2033幎ãŸã§ã®7.4%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãããããã£ãŒã«è¡æ¶²åéè£ çœ®åžå Žã¯ãç é¢å šäœã®éèŠå¢å ã«ãã£ãŠé§åãããå®å®ããæé·ãç®æããŠããŸã, 蚺æå®éšå®€å®¶åºå å»çã åžå Žã¯æè¡ã®é²æ©ã«ãã£ãŠæšé²ãããå¿è匷ãå®å šã«çŠç¹ãåãããŸãããããŠæå¹ã§ãä¿¡é Œã§ããè¡ã®ã³ã¬ã¯ã·ã§ã³æ¹æ³ã®å¿ èŠæ§ã éèŠãªåŸåã¯ãã¯ãŒã¯ãããŒãåçåããçäœé©åæ§ããã³ç°å¢ã«åªããææã®æ¡çšã«ãããæ±... ãã£ãšèŠã
ã¹ãã·ã£ã«ããŒãºãããŒã«ãŒåžå Žæ©ãããšãã§ããªã人ã«ã¯ãç¹å¥ãªå¿ èŠãããŒã«ãŒã䟿å©ã§ãã ç¹å¥ãªå¿ èŠæ§ã®ãããŒã«ãŒã¯ã身äœçæ¡ä»¶ã«èŠããã§ãã人ããè¡°éããŠããå€ã幎霢ã®çºçã«èŠãã人ã®èªç¥ãšç€ŸäŒçãªçºå±ãæå€§åããæ©äŒãæäŸããŸãã ãã®éçºæ®µéã§ã¯ãã¢ããªãã£ã®åé¡ãæã€åäŸã«ãšã£ãŠã¯ããã奜å¥å¿æºçã§ãç°å¢ãæ¢æ±ããŠããŸãã ç¹å¥ãªå¿ èŠæ§ã®ãããŒã«ãŒã¯åäŸãã³ãã¥ããã£ããã³ããã«ãã£ãŠåœŒãã®ä»²éã«å ãããé©åãªæ©èœããã³ç¬ç«ãä¿é²ããããšãå¯èœã«ããŸãã çŸåšãæ¥æ¿ãªé«éœ¢åãé«éœ¢åçççäŸã®å¢å ã麻çºã«ããç¹å¥ã®å¿ èŠæ§ã®ãããŒã«ãŒåžå Žã¯éåžžã«é åçã§ãã ãŸããäžçåå°ã®ããŸããŸãªæ¿åº... ãã£ãšèŠã
æ¯ç§3Då°å·ã¯å»ºç¯ææã®ããã®è€æ°ã®å±€ã®ã€ã¡ãŒãžãçµã¿èŸŒãããã«3次å ã€ã¡ãŒãžãäœæããã®ã«äœ¿çšãããæ·»å ç©ã®è£œé æ¥ã§ãã ãããã®ãªããžã§ã¯ãã¯ãã³ã³ãã¥ãŒã¿ãšã€ãèšèšãMRIã¹ãã£ã³ãªã©ã®ããžã¿ã«3DéåçããçæãããŸãã ãããã®è£ 眮ã¯èšèšè ãä»å çãªçšå ·ãè£ çœ®ãªãã§å€æŽãå ããããšãå¯èœã«ããŸãã æ¯ç§3Dã®å°å·ã¯è¯è³ª3Dã®å°å·ã®æè¡ãããŸããŸãªæ¯ç§ææãšçµåããŸãã ãã®æè¡ã¯ãæ¯ç§å»ãç¯æ£å»ãæ¯ç§æåž«ã«ãã£ãŠæ¡çšãããŸãã ããã¯è²»çšå¹æã倧ããã§ãããããããèšèšãå¯èœã«ããåºç¯ãªã«ã¹ã¿ã åãå¯èœã«ããŸãã ããã«ãããæ¯ç§éæ¥å»ã¯ã幎霢ã身é·ãäœéãå»çæŽãªã©ã®æ£è ã®ããŸããŸ... ãã£ãšèŠã
åçå人工ç®èåžå Žäžçåå°ã«ç°åžžç®èçŒè·¡ãå¢å ããŠããŸãã èã®æªæãå€å·ãç«å·ãè ããçåœã¯ãç®èãå埩ããå°æ¥ã®å䜵çãé¿ããããã«ãçŽã¡ã«å€ç§æè¡æé ãå¿ èŠã§ãã ç®ã®çŒè·¡ã¯3ã€ã®ã¬ãã«ãããªãã¡1stã2ndããã³3床ã®çŒè·¡ã«åºãåé¡ãããŸãã 3床ç®ã®ç«å·ã§ã¯ãç®èãå°ãªãããäžæ£ç¢ºãªç®èããªãå Žåã人工ç®èç§»æ€ã¯æãæçšãªæ²»çãªãã·ã§ã³ã§ãã 人工çãªç®ã¯å·ãèŠããä¿è·ãããŸãèªç¶ãªç®ã®åçãä¿é²ããŸãã人工ç®èã¯éåžžãäœã«ãã£ãŠç°¡åã«å埩ããæ£éšã«æ°ããç®èã®çæã容æã«ããã³ã©ãŒã²ã³ãã調補ãããŸãã ã¢ã¡ãªã«ã³ã»ããŒã³åäŒã«ãããšã486,000人ã®äººãæªæå¹Žã®ç«å·ã®æ²»çãå... ãã£ãšèŠã
èé¢ç¯ããæå·ããè»éªšãçµç¹ãå¥é¢ãã人工èã€ã³ãã©ã³ãã§äº€æããŸãã éšåçãªèé¢ç¯çã¯ãè骚é¢ç¯çã§å°æ°ã®äººã®ããã®åèšèã®äº€æã«ä»£ãããã®ã§ãã ãã®åãæ¿ãçæ³ã§ã¯ãèè»éªšã®æå·ããéšåã ãã¯ãæå·ãç¹å®ã®èã®ã³ã³ããŒãã¡ã³ãã«å¶éããããšããçªèµ·ã§åè§£éãããŸãã éšåçãªã€ã³ãã©ã³ãã³ã³ããŒãã³ãã¯ã暪æ¹åã®unicondylarã³ã³ããŒãã³ããã¡ãã£ã¢ã«ã®unicondylarã³ã³ããŒãã³ããããã³patellofemoralã³ã³ããŒãã³ãã®é åã§åä»ããããŸãããLateralãã¯èé¢ç¯ã®å€åŽã®ã³ã³ããŒãã¡ã³ãã§ãããèã®å察éšåããæãé ã ãMedialãããžã§ã€ã³ãã®å åŽ... ãã£ãšèŠã
䞡芪ããåäŸãŸã§ããŸãã¯å¹Œå°æãŸãã¯æäººæã«åŸã ã«çºéããããšããããŸãã ãªãŒããœãã«ã»ãããã³ãããŸãã¯ååž°ãXãªã³ã¯ããŸãã¯ããã³ã³ããªã¢é¢é£ã åºçæã«ååšããé£èŽã¯ãå 倩ã®é£èŽãšããŠç¥ãããŠããŸããèŽèŠåªå€±ã®åå ãšãªãéºäŒçèŠå ã«ã¯ãPendredçå矀ãUsherçå矀ãããã³otosclerosisãå«ãŸããŸããéºäŒçé£èŽã¯ãå°é»æ§é£èŽãšæèŠçé£èŽã®äž¡æ¹ã«ããããšãã§ããŸãã å åŽã®è³æèŠã®ãã¢ã»ã«ã¯ãå éšè³ããè³ãžã®ã³ã¯ã¬ã¢ç¥çµããé³ãäŒéãããããã®å°ããªé«ªçްèãžã®æå·ã¯ãæèŠçãªèŽèп倱ããããããŸããè³(äž¡åŽã®é£èŽ)ãŸãã¯çè³(åŽé¢ã®é£èŽ)ã®äž¡æ¹ã§æèŠçãªé£èŽãçºçããã... ãã£ãšèŠã
å€ç§å®å šã¬ã©ã¹ã¯äœäžããã³ãšãŒããŸã«ã®çŽæ¥äŒéãããŠãŒã¶ãŒãä¿è·ããŸãã æ £ç¿çãªåŠæ¹ã¡ã¬ãã³ã³ã¿ã¯ãã¬ã³ãºãåšå²ã«ãªãä¿è·ã¡ã¬ãã¯ãé©åãªä¿è·ãæäŸããããããã£ãŠãå»çå°éå®¶ã«ãã£ãŠæšå¥šãããŠããŸããã 鲿ã³ãŒãã£ã³ã°ã«ããå®å šã¡ã¬ãã¯ãæè¡äžã«ããŸããŸãªè§åºŠããæ¥ãããšãã§ããã¹ãã©ãã·ã¥ããšã¢ããŸã«ãããã³ãšã¢ããããã¬ããã«å¯Ÿããä¿¡é Œæ§ãšå®çšçãªçŒã®ä¿è·ãæäŸããŸãã ã¡ã¬ãã®ææ°ã®ã¢ãã«ã¯ãæå°éã®ã®ã£ããã§åŠæ¹çŒé¡ãããé©åã«ãã£ããããŸã(ç¹ã«çŒã®è§ããé¡ãŸã§ãç¹ã«å¹æçã§ããããã«ãã¡ã¬ãã¯ãŽã£ãããã£ããããªããã°ãªããŸãã)ã 玫å€ç·(UV)ã§ã¯ãçè²ãããã¬ã©ã¹ã¯ãã... ãã£ãšèŠã
çœã®éšé³ã¯ãç°å¢ã§èªç¶ã«èµ·ããä»ã®é³ããã¹ã¯ããããã«äž»åŒµãããé³ã§ãã ãã¯ã€ããã€ãºã¯ã20ã20,000ãã«ãã®å¯èŽåšæ³¢æ°ç¯å²å šäœã§åãåºããæã£ãŠããŸãã è²ã¹ãã¯ãã«ã®ããããå¯èŠæ³¢é·ã§æ§æãããçœè²å ã«é¡äŒŒããŠããŸãã çœãéšé³æ©æ¢°ã¯å¥å šãªè£ 眮ã§ããããç¡ç ãä¿é²ããããå€ãã®æ °ãã®å¯å®€ã®å€§æ°ãé ãã®ãå©ããŸãã ãããã®ã¬ãžã§ããã¯ãé³¥ãã²ã£ããè¿ããçœã®éšé³ããã®ä»ã®éšé³è²ã«å ããŠæ³¢ãã¯ã©ãã·ã¥ãããªã©ã®åšå²ãšèªç¶çãªé³ãé »ç¹ã«æäŸããŸãããŸãã乳幌å ã®å¯å ·ãšããŠãã䜿ãããŠããŸãã èµ€ã¡ãããããã«ç ãã®ãå©ãããããããªãèæ¯ã®çœãéšé³ã 乳幌å ã®ããã®ããã€ãã®çœããã€ãº... ãã£ãšèŠã
ANAãŸãã¯FANA(èå ææ žæäœ)ãšãåŒã°ããææ žæäœæ€æ»ã¯ãäœå ã§çºçããè¡æŒ¿äžã®èªåæäœã®ååšã倿ããè¡æ¶²æ€æ»ã§ãã éåžžã®æ¡ä»¶ã§ã¯ã人äœã®å ç«ã·ã¹ãã ã¯ã现èããŠã€ã«ã¹ãçèãªã©ã®ç°ç©ãèªèãããããã®ç°ç©ã«å¯Ÿããå ç«åå¿ãçæããŸãã ãã®å ç«åå¿ã¯ãäœå ã®ä»»æã®ç°ç²åãçµåããç Žå£ãã倿°ã®æäœã®çç£ãå«ã¿ãŸãã ãããããã èªå·±å ç«çŸæ£ å šèº«æ§Lupus Erythematosus(SLE)ãRheumatoidé¢ç¯çãSclerodermaãSjogrençå矀ãªã©ã®æ¡ä»¶ã¯ãäœã¯ç¬èªã®çްèãç°äœãšããŠèªèããç¬èªã®çްèã«å¯Ÿããææ žæäœãçæããŸãã ãããã®ææ žæäœã¯ã现è... ãã£ãšèŠã
èæ€å€åœ¢ã¯ããããŒèæ€ã®åã®ç°åžžãªçŽç·ãŸãã¯æ²ç·ã§ãã ããã¯ãèåãå·å®³ãåã®çµæãšããŠèµ·ããããšãã§ããŸã èæ€æè¡ãåºç£äžè¯ããŸãã¯åäŸã®æé·ã 倧人ã§ã¯ãèæ€å€åœ¢ã®æãäžè¬çãªã¿ã€ãã¯ã倿§èæ±çã§ãã倧人ã®è骚ã®å€åœ¢ã®å€§ããªçç¶ã¯ãäžããäžãŸã§ãè¶³ãè¶³ã®çã¿ã匱ã¿ãå«ãŸããŸãã 倿§èæ±çã®çµéšã®çã¿ã䌎ããã¹ãŠã®æäººã§ã¯ãããŸãããã°ããŒãã« æäººã®èæ€å€åœ¢åžå Ž: ãã€ãããã¯ã¹åžå Žã®äž»èŠãªéžæã¯ã補åèµ·åãæ¿èªãªã©ã®æé·æŠç¥ã«çŠç¹ãåœãŠãŠããŸã, äºæž¬æéäžã®åžå Žã®æé·ãé§åããããšãæåŸ ãããŠããŸã. äŸãã°ã2021幎9æã«ã¯ãèé«éå®³ã®æè¡ãœãªã¥ãŒã·ã§ã³ã«çŠç¹ãåœãŠãå»çæ... ãã£ãšèŠã
å¿å®€é »æã¢ãã¬ãŒã·ã§ã³åžå Žãã¢ãã¬ãŒã·ã§ã³ã®çš®é¡å¥ïŒé«åšæ³¢ã¢ãã¬ãŒã·ã§ã³ãå·åã¢ãã¬ãŒã·ã§ã³ãã¬ãŒã¶ãŒã¢ãã¬ãŒã·ã§ã³ããã€ã¯ãæ³¢ã¢ãã¬ãŒã·ã§ã³ïŒããã¯ãããžãŒå¥ïŒã«ããŒãã«ããŒã¹ã®ã¢ãã¬ãŒã·ã§ã³ããã³éã«ããŒãã«ããŒã¹ã®ã¢ãã¬ãŒã·ã§ã³ïŒãé©å¿çå¥ïŒèè¡æ§å¿å®€é »æãéèè¡æ§å¿å®€é »æãããã³ç¹çºæ§å¿å®€é »æïŒãåŠçœ®ã¿ã€ãå¥ ïŒå¿å€èã¢ãã¬ãŒã·ã§ã³ããã³å¿å èã¢ãã¬ãŒã·ã§ã³ïŒã補åã¿ã€ãå¥ïŒã¢ãã¬ãŒã·ã§ã³ã«ããŒãã«ããããã³ã°ã·ã¹ãã ãã¬ã€ãã·ãŒã¹ããšãã«ã®ãŒæºããã®ä»ïŒé»æ¥µãªã©ïŒïŒã幎霢局å¥ïŒå°å ãæäººãé«éœ¢è ïŒãçšéå¥ïŒå¿å®€é »ææ²»çãå¿æ¿çް忲»çããã®ä»ïŒäŒå°é害ãªã©ïŒïŒããšã³ããŠãŒã¶ãŒå¥ (ç é¢... ãã£ãšèŠã
åç²§åã®å€ç§ã¯å€ç§ããã³å»åŠã®æè¡ã«ãã£ãŠäººã®åºçŸãæ¹åããããšã«çŠç¹ãåãããè¬ã®ç¬ç¹ãªæã§ãã é éšãéŠãäœã®ãã¹ãŠã®é åã§åç²§åæè¡ãè¡ãããšãã§ããŸãã 人ã®å€èгãèªå°å¿ãèªä¿¡ãåäžãããããšãç®æããŠããŸããåç²§åã¯ãäžè¬çã«å建ããã³é»æ°ççŸå®¹å€ç§ã§ãã2çš®é¡ã®æè¡ãå«ã¿ãŸãã å建æè¡ã¯ãéåžžãç®ã«èŠããå·ãç®èã®ç¶æ ããŸãã¯æªæãæè¡ãç æ°ããŸãã¯åºç£äžè¯ã«ãã£ãŠåŒãèµ·ãããã身äœéšåã®å€èŠ³ãæ¹åããããã«è¡ãããŸãã éžæçãªåç²§åã®æè¡ã¯éåžžéå»åŠçãªçç±ã®ããã«è¡ãããŸãã ããã¯ããã¡ã·ãªããå«ã, breast ã€ã³ãã©ã³ããèèªåžåŒè¡ããã³breastã®æžå°ã¯æ£è ã®... ãã£ãšèŠã
ã¢ããé žã¯ã¿ã³ãã¯è³ªã®åºæ¬çãªæ§é åäœã§ãã ã¢ããé žåæã¯ããã€ãªãã¯ãããžãŒåŠçããã€ãªåæçãããã³çååŠç£æ¥ã«ãããäžè¬çã«äœ¿çšãããåææè¡ã§ãã ã¢ããé žã®æ€å åã¯èçœè³ªããããããã«ååšããã¢ããé žã®å®æ§ãããŠéçãªåæã®ããã«ãèçœè³ªããã³ãããããã®æ£ç¢ºãªç¹åŸŽåãå©ããŸã䜿çšãããŸãã ã¢ããé žã®æ€å åã«ã®ãããªç æ°ã®èšºæã®ãããããªé©çšããããŸã ãã§ãã«ã±ãã³ãªã¢, hyperammonemia and seizures, é£åé ç®ã®æ é€å€ã®æšå®, è¬ã®çºèŠç ç©¶.ã°ããŒãã« ã¢ããé žã¢ãã©ã€ã¶ãŒ åžå Ž: ãã€ãããã¯ã¹äžçã®ã¢ããé žã®æ€å åã®åžå Žã®ããã®ç¬¬äžæ¬¡é転è ã¯äººé... ãã£ãšèŠã
æ£è ã®ååãœãªã¥ãŒã·ã§ã³åžå ŽèŠæš¡ãšäºæž¬è¿ã â 2026幎ïœ2033幎æ£è ã®ååãœãªã¥ãŒã·ã§ã³åžå ŽèŠæš¡ãæšå®ãããã°ããŒãã« 2026幎ã®USD 4.7åã§è©äŸ¡ãããUSD 9.8ã«éããèŠèŸŒã¿ 2033幎(æå20幎)10幎(æå40幎)10幎(æå40幎) 2026ã2033幎11æ2%ãããã£ãŒã«è¿æ¥è ååéãœãªã¥ãŒã·ã§ã³ã¯ãå忀æ»ãè¡ãã³ã³ãã¯ããªèšºæã·ã¹ãã ã§ãã éäžçãªç ç©¶æã§ã¯ãªããã±ã¢ã®ãã€ã³ãã«è¿ãã§ãã ãããã®è£œåã¯ããµã³ãã«ã®æºåãå¢å¹ ãããã³ è¿ éã§ãè¿ éã§ããã€è¿ éã«æäŸã§ãããŠãŒã¶ãŒãã¬ã³ããªãŒãªãã©ãããã©ãŒã ãžã®æ€åº æ£ç¢ºãªçµæã ç é¢ã蚺çæãéåžžå€ã§... ãã£ãšèŠã
錻ã¢ããã€ã¶ããã€ã¹åžå ŽèŠæš¡ãšäºæž¬ â 2026 â 2033幎äžç錻ã¢ããã€ã¶ããã€ã¹åžå ŽèŠæš¡ãæšå®ããã 2026幎ã®USD 1.2åã§è©äŸ¡ãããUSD 2.3ã«éããèŠèŸŒã¿ 2033幎10æãååç©å¹Žéæé·ç(CAGR)ã92%å¢ 2026幎ïœ2033幎ãããã£ãŒã«ããµã« ã¢ããã€ã¶è£ 眮ã¯è¬ãæž¡ãããã«èšèšãããŠããå»çæ©åšã§ã 现ãããã¹ãã®åœ¢ã§éŒ»è ã«ã ãããã®ããã€ã¹ãæå¹ 錻ç²èã«ããè¿ éãªåžåããã€ãã¹ èè žãã©ã¯ããšãã¡ãŒã¹ããã¹ä»£è¬ã ãããã¯ãã¯ç®¡çã®ããã«äœ¿çšãããŸã ã¯ã¯ãã³ãçã¿è¬ãããããœããªã©ã®ç·æ¥è¬ãããã³ ã¢ã¬ã«ã®ãŒãŸãã¯çé çã®æ²»çã ã·ã³ã°ã«ãŠãŒã¹ã§ãå©... ãã£ãšèŠã
ååãäžããããæåç é¢ã®ãããã®åžå ŽèŠæš¡ããã³äºæž¬â 2026 â 20332026幎ãã2033幎ãŸã§ã®USD 5.2åç±³ãã«ã§åžå ŽèŠæš¡ãè©äŸ¡ãããUSD 8.9åç±³ãã«ã«2033åãã«ã«éãããšäºæ³ãããŸãããããã£ãŒã«ååãäžããããããã³æåç é¢ã®ãããã¯å¿è匷ãå¿é ã®ç°å¢ã§äœ¿çšãããå¿ é ã®å¿è匷ããµããŒã ã·ã¹ãã å¿èåŒ·ãæ °ããå®å šããã³èšåºã¯ãŒã¯ãããŒãé«ããŸãã ããã¥ã¢ã«ãããã¯ãä»è·è ã«ããç©ççãªèª¿æŽãå¿ èŠãšããŸã, ååãäžãããããããã¯é«ãã調æŽããããã«é»åã¢ãŒã¿ãŒã䜿çšããŸã, ããã¯ã¬ã¹ã, èã®äœçœ®, ãã㊠Trendelenburg/éã®èšå®. é«åºŠãªã¢... ãã£ãšèŠã
ã°ããŒãã«ããŒã¿ãã«èšºæè£ 眮åžå ŽèŠæš¡ãšäºæž¬ - 2026 - 2033äžççãªããŒã¿ãã«èšºæè£ 眮åžå ŽèŠæš¡ã¯ã2026幎ã«12.4åç±³ãã«ã§è©äŸ¡ããã2033幎ãŸã§ã«21.6åç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«äžççãªæºåž¯çšèšºæè£ 眮ã¯åºãç¯å²ãå å²ããŸã ãã³ããã«ã ãŸãã¯åŸæ¥ã®å®éšå®€ã®èšå®ã®å€ã§å»åŠã®ãã¹ããããã®ã«äœ¿çšãããç§»ååŒå𿢰ã ãããã®è£œåã¯ãããŒã¿ãã«è¶ 鳿³¢ãŠãããããã³ããã«ãè¡æ¶²ã¢ãã©ã€ã¶ãæ¥éãªãã¹ãããã(äŸãã°ãææç)ãã¢ãã€ã«ECGãã·ã³ãããã³ãã€ã³ããªãã±ã¢åå蚺æãã©ãããã©ãŒã ãå«ã¿ãŸãã æºåž¯çšèšºæè£ 眮ã¯å»é¢ãç·æ¥ã®å¿é ãããŒã ã±ã¢ããã³é éãè³... ãã£ãšèŠã
ããŒã¿ãã«è³æå·ã¹ãã£ããŒåžå ŽèŠæš¡ãšäºæž¬ - 2026 - 20332026幎ãã2033幎ãŸã§ã®15.6%ã®ååç©ã®å¹Žéæé·ç(CAGR)ãå±ç€ºãã2033幎ãŸã§ã®USD 1.45åã§è©äŸ¡ãããUSD 3.95åã«éãããšäºæ³ãããŸãããããã£ãŒã«æºåž¯çšè³ã®å·å®³ã®èµ°æ»åšã¯å€å·æ§ã®è³ã®å·å®³(TBIs)ãè©äŸ¡ããããã«èšèšãããŠããå¯éãã蚺æã€ã¡ãŒãžæå°è£ 眮ã§ã ã±ã¢ã®ãã€ã³ããåãåãã ãããã®è£ 眮ã¯ãè¿èµ€å€ç·åå æ³(NIRS)ãããŒã¿ãã«CTããŸãã¯ãã€ã¯ããŠã§ãŒãã€ã¡ãŒãžã³ã°ãªã©ã®æè¡ã䜿çšããŠãéç·åœ¢åºè¡ãèšåŒµããŸãã¯é è骚æãæ€åºããããšãã§ããŸãã ç·æ¥éšãææ¥è»ãã¹ããŒãã»ãã... ãã£ãšèŠã